Nabriva Therapeutics plc (NBRVF)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Oct 2, 2025
Nabriva Therapeutics Market Cap
Nabriva Therapeutics has a market cap or net worth of $323.00 as of October 3, 2025. Its market cap has decreased by -99.99% in one year.
Market Cap
323.00
Enterprise Value
n/a
Revenue
29.56M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since September 18, 2015, Nabriva Therapeutics's market cap has decreased from 26.22M to 323.00, a decrease of -100.00%. That is a compound annual growth rate of -67.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2025 | 323.00 | 10,666.67% |
| Dec 30, 2024 | 3.00 | - |
| Dec 29, 2023 | 3.00 | -100.00% |
| Dec 30, 2022 | 5.79M | -82.95% |
| Dec 31, 2021 | 33.97M | -33.41% |
| Dec 31, 2020 | 51.01M | -59.13% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Tian'an Technology Group | 718.73M |
| Elite Pharmaceuticals | 687.00M |
| Glass House Brands | 598.71M |
| Northwest Biotherapeutics | 364.70M |
| CytoDyn | 326.79M |
| Nika Pharmaceuticals | 301.74M |
| American Oncology Network | 273.17M |